Research Fellowship in Substance Abuse Disorder

药物滥用障碍研究奖学金

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Division on Substance Abuse of the Columbia University Department of Psychiatry and the New York State Psychiatric Institute established a 2-year postdoctoral program that focuses on training physicians and psychologists for research careers in substance abuse. The main goal of this program, which is now in its 19th year of existence, is to provide both the research skills and clinical expertise necessary to design and carry out research on the etiology and treatment of substance use disorders. In this competing application we are requesting 5 additional years of funding for 5 fellows to be enrolled in the program each year. The program continues to include the following aspects of training: 1) Didactic introduction to clinical research in the addictions that incorporates a comprehensive overview of the substance abuse field, an introduction and advanced course in statistics, a weekly journal club and methodology seminar, and a formal course and ongoing instruction on the ethical and appropriate scientific conduct of clinical research; 2) Research apprenticeship where each trainee works as a junior collaborator under the close supervision of a senior investigator who serves as a preceptor and mentor; 3) Clinical experience in the major modalities used to treat substance abuse; and 4) Development of teaching capabilities where each fellow is provided opportunities to provide lectures/seminars to medical students, psychiatric and other medical house staff and/or present at journal clubs and scientific meetings. A new direction in the past 5 years has been to recruit and train MD/PhD candidates who concentrate on translational paradigms to better understand the physiologic and behavioral mechanisms associated with substance abuse. In the 19 years that the program has been running there has been a steady flow of high quality applicants. 47 trainees (31% females) have entered the program, including 34 physicians (30 psychiatrists, 1 neurologist, 2 internists, 1 family medicine), 1 nurse practitioner with a doctorate in public health, and 12 psychologists. In the past 5 years 3 of the physicians have been MD/PhDs. Of those who graduated in the past 10 years, 71% have gone on to academic-research positions, and 24% have entered academic clinical/teaching positions in which several have remained actively involved in research activities. Six fellows (one on a supplemental slot) are currently in training and two additional fellows will begin training in July 2012. The program has been successful in recruiting women and minority trainees. In parallel to this successful training program the faculty within the Division has continued to grow, enriched by the graduating fellows. At the first grant submission there were 9 faculty members within the Division on Substance Abuse. Currently, there are 23 faculty members, of which 11 are capable of serving as mentors. This sustained growth demonstrates how vibrant the Division on Substance Abuse is for young investigators.
描述(由申请人提供):哥伦比亚大学精神病学系的药物滥用部和纽约州精神病学研究所建立了一项为期两年的博士后计划,专注于培训药物滥用的研究医生和心理学家。该计划的主要目标是现存了19年,它是提供研究和进行有关物质使用障碍的病因和治疗研究所必需的研究技能和临床专业知识。在此竞争申请中,我们要求每年为5名研究员提供5年的资金。该计划继续包括培训的以下方面:1)成瘾中临床研究的教学介绍,其中包含了对药物滥用领域的全面概述,统计学的介绍和高级课程,每周期刊俱乐部和方法论研讨会,以及关于伦理和适当的临床研究的正式和持续的教学和持续的教学; 2)研究学徒制,每个学员在高级调查员的密切监督下担任初级合作者,他担任主教和导师; 3)用于治疗药物滥用的主要方式的临床经验; 4)开发教学能力,每个研究员都有机会为医学生,精神科和其他医疗机构工作人员和/或在期刊俱乐部和科学会议上提供讲座/研讨会。在过去的5年中,一个新的方向是招募和培训MD/PHD候选者,他们专注于转化范式,以更好地了解与药物滥用相关的生理和行为机制。在该计划运行的19年中,高质量的申请人稳定流动。 47名学员(31%的女性)已进入该计划,其中包括34名医生(30名精神科医生,1名神经科医生,2名内科医生,1名家庭医学),1名护士从业人员拥有公共卫生博士学位,还有12位心理学家。在过去的5年中,有3位医生是MD/PHD。在过去10年中毕业的人中,有71%的人担任了学术研究职位,而24%的人进入了学术临床/教学职位,其中一些人仍在积极参与研究活动。目前正在培训六名研究员(一个补充老虎机)正在接受培训,2012年7月将开始培训两个研究员。该计划已成功地招募了妇女和少数民族学员。与这项成功的培训计划的同时,该部门内的教职员工不断增长,并在毕业的研究员中丰富。在第一次赠款提交中,该部门内有9名教职员工滥用毒品。目前,有23名教职员工,其中11位能够担任导师。这种持续的增长表明,对于年轻的研究人员而言,滥用药物的分裂是多么活跃。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frances Rudnick Levin其他文献

Frances Rudnick Levin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frances Rudnick Levin', 18)}}的其他基金

Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder
利用内侧前额叶和前扣带皮层的 rTMS 增强认知行为疗法治疗可卡因使用障碍
  • 批准号:
    10681981
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
开发 PPL-138,一种用于治疗可卡因使用障碍的新型混合 NOP/Mu 部分激动剂
  • 批准号:
    10707176
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
开发 PPL-138,一种用于治疗可卡因使用障碍的新型混合 NOP/Mu 部分激动剂
  • 批准号:
    10616932
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies
AEF0117 作为大麻使用障碍潜在治疗方法的进展:临床前毒性和临床药代动力学研究
  • 批准号:
    10668477
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
The CB1 Signaling-Specific Inhibitor, AEF0117, for Cannabis Use Disorder: A Multi-Site Treatment Trial
CB1 信号传导特异性抑制剂 AEF0117,用于治疗大麻使用障碍:多部位治疗试验
  • 批准号:
    10249716
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues
使用芬太尼类似物缓释丁丙诺啡与舌下含服丁丙诺啡治疗阿片类药物使用障碍患者的随机对照试验
  • 批准号:
    9979016
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues
使用芬太尼类似物缓释丁丙诺啡与舌下含服丁丙诺啡治疗阿片类药物使用障碍患者的随机对照试验
  • 批准号:
    10158460
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders
大麻素的共同药物治疗策略
  • 批准号:
    9098672
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders
大麻素的共同药物治疗策略
  • 批准号:
    8742325
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders
大麻素的共同药物治疗策略
  • 批准号:
    9306809
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
  • 批准号:
    10751224
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
  • 批准号:
    10825287
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了